These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 3814682

  • 41. Reversal of abnormal dexamethasone suppression test in alcoholics abstinent for four weeks.
    Del Porto JA, Monteiro MG, Laranjeira RR, Jorge MR, Masur J.
    Biol Psychiatry; 1985 Nov; 20(11):1156-60. PubMed ID: 4052517
    [Abstract] [Full Text] [Related]

  • 42. [Endocrinologic testing of alcoholics with depressive states--with special reference to the dexamethasone suppression test].
    Suwa K, Takano K, Nishijima K, Ishiguro T, Enomoto M.
    Seishin Shinkeigaku Zasshi; 1983 Nov; 85(11):823-6. PubMed ID: 6677920
    [No Abstract] [Full Text] [Related]

  • 43. Enhanced adrenal sensitivity to exogenous cosyntropin (ACTH alpha 1-24) stimulation in major depression. Relationship to dexamethasone suppression test results.
    Jaeckle RS, Kathol RG, Lopez JF, Meller WH, Krummel SJ.
    Arch Gen Psychiatry; 1987 Mar; 44(3):233-40. PubMed ID: 3030218
    [Abstract] [Full Text] [Related]

  • 44. [In unipolar depression does the response to the dexamethasone suppression test predict a symptomatic recurrence after clinical cure?].
    Charles G, Schittecatte M, Maes JM, Rush AJ, Wilmotte J.
    Acta Psychiatr Belg; 1986 Mar; 86(3):249-56. PubMed ID: 3751648
    [Abstract] [Full Text] [Related]

  • 45. REM latency and DST results.
    Mendlewicz J.
    Am J Psychiatry; 1984 Mar; 141(3):473-4. PubMed ID: 6703125
    [No Abstract] [Full Text] [Related]

  • 46. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M, Schweiger U, Gotthardt U, Weber B, Körner A, Schmider J, Standhardt H, Lammers CH, Krumm B, Heuser I.
    Biol Psychiatry; 1998 May 15; 43(10):762-6. PubMed ID: 9606531
    [Abstract] [Full Text] [Related]

  • 47. Is conversion disorder biologically related with depression?: a DST study.
    Tunca Z, Fidaner H, Cimilli C, Kaya N, Biber B, Yeşil S, Ozerdem A.
    Biol Psychiatry; 1996 Feb 01; 39(3):216-9. PubMed ID: 8837984
    [No Abstract] [Full Text] [Related]

  • 48. Pathophysiology of HPA axis abnormalities in patients with major depression: an update.
    Kathol RG, Jaeckle RS, Lopez JF, Meller WH.
    Am J Psychiatry; 1989 Mar 01; 146(3):311-7. PubMed ID: 2645793
    [Abstract] [Full Text] [Related]

  • 49. Learned helplessness: an experimental model of the DST in rats.
    Haracz JL, Minor TR, Wilkins JN, Zimmermann EG.
    Biol Psychiatry; 1988 Feb 15; 23(4):388-96. PubMed ID: 3342268
    [Abstract] [Full Text] [Related]

  • 50. DST in bulimia without endogenous depression.
    Levy AB, Dixon KN.
    Biol Psychiatry; 1987 Jun 15; 22(6):783-6. PubMed ID: 3593818
    [No Abstract] [Full Text] [Related]

  • 51. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
    Poland RE, Rubin RT, Lesser IM, Lane LA, Hart PJ.
    Arch Gen Psychiatry; 1987 Sep 15; 44(9):790-5. PubMed ID: 3632252
    [Abstract] [Full Text] [Related]

  • 52. Association performance and the DST.
    Demeter E, Rihmer Z, Arato M, Frecska E.
    Psychiatry Res; 1986 Jul 15; 18(3):289-90. PubMed ID: 3749388
    [No Abstract] [Full Text] [Related]

  • 53. Prediction of outcome in depressed patients by weekly monitoring with the dexamethasone suppression test.
    Schweitzer I, Maguire KP, Gee AH, Tiller JW, Biddle N, Davies B.
    Br J Psychiatry; 1987 Dec 15; 151():780-4. PubMed ID: 3502804
    [Abstract] [Full Text] [Related]

  • 54. HPA axis abnormalities in depressed patients with normal response to the DST.
    Meller W, Kathol RG, Jaeckle RS, Grambsch P, Lopez JF.
    Am J Psychiatry; 1988 Mar 15; 145(3):318-24. PubMed ID: 2830798
    [Abstract] [Full Text] [Related]

  • 55. Cortisol levels in plasma after dexamethasone administration and the nosology of depression.
    Sanchez Blanque A, Fernandez Canti G, Gimenez Morales JC, Juste Rullo G.
    Acta Psychiatr Belg; 1985 Mar 15; 85(3):406-15. PubMed ID: 4050499
    [Abstract] [Full Text] [Related]

  • 56. Mixed anxiety-depressive disorder and major depressive disorder: comparison of the severity of illness and biological variables.
    Kara S, Yazici KM, Güleç C, Unsal I.
    Psychiatry Res; 2000 Apr 24; 94(1):59-66. PubMed ID: 10788678
    [Abstract] [Full Text] [Related]

  • 57. The dexamethasone suppression test in a general hospital psychiatric setting.
    Warneke LB.
    Can J Psychiatry; 1985 Dec 24; 30(8):614-8. PubMed ID: 4084903
    [Abstract] [Full Text] [Related]

  • 58. What does the dexamethasone suppression test identify?
    Krishnan KR, France RD, Pelton S, McCann UD, Manepalli AN, Davidson JR.
    Biol Psychiatry; 1985 Sep 24; 20(9):957-64. PubMed ID: 4027315
    [Abstract] [Full Text] [Related]

  • 59. The dex/CRH test--is it better than the DST?
    Watson S, Gallagher P, Smith MS, Ferrier IN, Young AH.
    Psychoneuroendocrinology; 2006 Aug 24; 31(7):889-94. PubMed ID: 16701957
    [Abstract] [Full Text] [Related]

  • 60. Effect of treatment on plasma cortisol and dexamethasone.
    Carson SW, Halbreich U.
    Biol Psychiatry; 1987 Feb 24; 22(2):213-6. PubMed ID: 3814671
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.